{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:24:54Z","timestamp":1788870294205,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pujiang Talent Project of the Shanghai Science"},{"name":"Technology Committee"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ejogrb.2012.10.036","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T07:48:03Z","timestamp":1354866483000},"page":"81-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"167","author":[{"given":"JiaYing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinBao","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voramon","family":"Sangvatanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2012.10.036_bib0005","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/1097-0142(19850501)55:9<2019::AID-CNCR2820550932>3.0.CO;2-2","article-title":"Factors influencing survival in carcinoma of the ovary. Study from a well-defined Swedish population","volume":"55","author":"Einhorn","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/gyno.2001.6460","article-title":"A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?","volume":"84","author":"Carney","year":"2002","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/gyno.1994.1179","article-title":"Prospective multicenter study on CA 125 in postmenopausal pelvic masses","volume":"54","author":"Maggino","year":"1994","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0029-7844(97)00075-6","article-title":"Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer","volume":"89","author":"Roman","year":"1997","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1016\/j.ejogrb.2012.10.036_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/AOG.0b013e3181d44053","article-title":"Predicting risk of malignancy in adnexal masses","volume":"115","author":"McDonald","year":"2010","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q","article-title":"Benign conditions associated with raised serum CA-125 concentration","volume":"75","author":"Buamah","year":"2000","journal-title":"Journal of Surgical Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","article-title":"The CA 125 tumour-associated antigen: a review of the literature","volume":"4","author":"Jacobs","year":"1989","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0040","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0045","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Medical Research Methodology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychological Methods"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9120","article-title":"A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy","volume":"9","author":"Dinnes","year":"2005","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2009.10.087","article-title":"Use of a symptom index, CA125, and HE4 to predict ovarian cancer","volume":"116","author":"Andersen","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0075","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ygyno.2008.04.041","article-title":"Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence","volume":"110","author":"Havrilesky","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0085","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.clinbiochem.2011.04.011","article-title":"Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases","volume":"44","author":"Park","year":"2011","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0090","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2008.19.2484","article-title":"Development of a multimarker assay for early detection of ovarian cancer","volume":"28","author":"Yurkovetsky","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0095","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jcla.20340","article-title":"The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass","volume":"23","author":"Montagnana","year":"2009","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0110","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumour Biology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3802\/jgo.2011.22.4.244","article-title":"Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass","volume":"22","author":"Partheen","year":"2011","journal-title":"Journal of Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0120","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2010.02.005","article-title":"Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass","volume":"117","author":"Nolen","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0130","first-page":"111","article-title":"HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses","volume":"11","author":"Abdel-Azeez","year":"2010","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2011.02.022","article-title":"No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting","volume":"121","author":"Jacob","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0140","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/IGC.0b013e31821a3726","article-title":"Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma","volume":"21","author":"Chang","year":"2011","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0145","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ijc.26129","article-title":"Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer","volume":"130","author":"Park","year":"2012","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0150","doi-asserted-by":"crossref","first-page":"358e1","DOI":"10.1016\/j.ajog.2011.05.017","article-title":"Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women","volume":"205","author":"Holcomb","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejogrb.2008.08.011","article-title":"Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review","volume":"142","author":"Medeiros","year":"2009","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.ejogrb.2012.10.036_bib0185","doi-asserted-by":"crossref","first-page":"228e1","DOI":"10.1016\/j.ajog.2010.03.043","article-title":"Comparison of a novel multiple marker assay vs the risk of malignancy index for the prediction of epithelial ovarian cancer in patients with a pelvic mass","volume":"203","author":"Moore","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512005027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512005027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:27:46Z","timestamp":1759555666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211512005027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0301211512005027"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.10.036","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}